0001209191-11-016770.txt : 20110309
0001209191-11-016770.hdr.sgml : 20110309
20110309194753
ACCESSION NUMBER: 0001209191-11-016770
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110302
FILED AS OF DATE: 20110309
DATE AS OF CHANGE: 20110309
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: THERAVANCE INC
CENTRAL INDEX KEY: 0001080014
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943265960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6508086000
MAIL ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: S. SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MEDICINE INC
DATE OF NAME CHANGE: 20000302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DRAZAN JEFFREY M
CENTRAL INDEX KEY: 0001032623
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 11676460
MAIL ADDRESS:
STREET 1: 2884 SAND HILL RD STE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
c13907_4x0.xml
MAIN DOCUMENT DESCRIPTION
X0303
4
2011-03-02
0001080014
THERAVANCE INC
THRX
0001032623
DRAZAN JEFFREY M
C/O SIERRA VENTURES
SAND HILL ROAD, SUITE 100
MENLO PARK
CA
94025
1
0
0
0
3% Convertible Subordinated Notes due 2015
25.87
2011-03-02
4
S
0
1593000
1743273
D
2015-01-15
Common Stock
61577
1600000
I
By Sierra Ventures VI, L.P.
3% Convertible Subordinated Notes due 2015
25.87
2011-03-03
4
S
0
1600000
1762933
D
2015-01-15
Common Stock
61848
0
I
By Sierra Ventures VI, L.P.
3% Convertible Subordinated Notes due 2015
25.87
2015-01-15
Common Stock
11867
307000
I
By SV Associates VI, L.P.
Convertible notes are exercisable at any time prior to the close of business on the business day immediately preceding the Expiration Date.
Price received includes $6,903.00 of accrued interest.
Reporting Person is a general partner of SV Associates VI, L.P., which is the general partner of Sierra Ventures VI, L.P. The Reporting Person disclaims beneficial ownership of these reported securities, except to the extent of his pecuniary interest therein.
Price received includes $6,933.33 of accrued interest.
Convertible notes held in the name of SV Associates VI, L.P. as nominee, of which $69,906.20 represents convertible notes held in the name of SV Associates VI, L.P. as nominee on behalf of the Reporting Person. The Reporting Person disclaims beneficial ownership of these reported securities, except to the extent of his pecuniary interest therein.
/s/ Jeffrey M. Drazan
2011-03-09